Pharmacy, Health Sciences, & Exercise Science

Impact of Rapid MecA Testing in Children with Staphylococcus aureus Bacteremia

Presenter Information

Emily Drwiega, Butler University

Document Type

Oral Presentation

Location

Indianapolis, IN

Start Date

13-4-2018 3:30 PM

End Date

13-4-2018 4:15 PM

Description

Rapid molecular technology can detect the mecA resistance gene in Staphylococcus aureus (SA), predicting methicillin susceptibility in under one hour. In combination with antimicrobial stewardship program interventions in adults with SA bacteremia, rapid mecA testing decreases time to targeted therapy. This intervention has not yet been shown effective in pediatric patients or in the absence of real-time stewardship interventions. The objective of this study was to determine if time to optimal therapy decreased following implementation of GeneXpert rapid diagnostic testing (RDT) in a pediatric institution without a formal antimicrobial stewardship protocol for response. The primary outcome was time to optimal therapy, determined by the number of hours from collection of the blood sample to the initiation of an optimal regimen.

This document is currently not available here.

Share

COinS
 
Apr 13th, 3:30 PM Apr 13th, 4:15 PM

Impact of Rapid MecA Testing in Children with Staphylococcus aureus Bacteremia

Indianapolis, IN

Rapid molecular technology can detect the mecA resistance gene in Staphylococcus aureus (SA), predicting methicillin susceptibility in under one hour. In combination with antimicrobial stewardship program interventions in adults with SA bacteremia, rapid mecA testing decreases time to targeted therapy. This intervention has not yet been shown effective in pediatric patients or in the absence of real-time stewardship interventions. The objective of this study was to determine if time to optimal therapy decreased following implementation of GeneXpert rapid diagnostic testing (RDT) in a pediatric institution without a formal antimicrobial stewardship protocol for response. The primary outcome was time to optimal therapy, determined by the number of hours from collection of the blood sample to the initiation of an optimal regimen.